Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
Health Technology » Pharmaceuticals Major
|JNJ||Johnson & Johnson||1.07%||171.79||0.7%||$1109.84m|
|MRK||Merck & Co., Inc.||1.36%||77.57||0.7%||$790.23m|
|LLY||Eli Lilly & Co.||2.47%||244.38||1.1%||$746.32m|
|BMY||Bristol-Myers Squibb Co.||0.50%||68.30||1.0%||$596.02m|
|NRXP||NRX Pharmaceuticals, Inc.||50.58%||24.77||0.0%||$151.02m|
|CERE||Cerevel Therapeutics Holdings, Inc.||-1.28%||24.67||0.2%||$150.47m|
|BHVN||Biohaven Pharmaceutical Holding Co. Ltd.||2.88%||126.46||0.0%||$93.69m|
|OGN||Organon & Co.||-3.66%||29.79||0.0%||$83.69m|
|RPRX||Royalty Pharma Plc||-0.07%||40.33||0.2%||$77.39m|
AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology, and dermatology; oncology, including blood cancers; virology, including hepatitis C virus (HCV) and human immunodeficiency virus (HIV); neurological disorders, such as Parkinson's disease; metabolic diseases, comprising thyroid disease and complications associated with cystic fibrosis; pain associated with endometriosis; and other serious health conditions. The company was founded on October 19, 2011 and is headquartered in North Chicago, IL.